Author Correction: Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
24 Jul 2020
Historique:
entrez: 26 7 2020
pubmed: 28 7 2020
medline: 28 7 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

pubmed: 32709976
doi: 10.1038/s42003-020-01135-5
pii: 10.1038/s42003-020-01135-5
pmc: PMC7381596
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

400

Commentaires et corrections

Type : ErratumFor

Auteurs

Anne-Lise Peille (AL)

Charles River Discovery Research Services Germany GmbH (formerly Oncotest GmbH), Am Flughafen 12-14, 79108, Freiburg, Germany.
4HF Biotec GmbH, Am Flughafen 14, Freiburg, 79108, Germany.

Vincent Vuaroqueaux (V)

Charles River Discovery Research Services Germany GmbH (formerly Oncotest GmbH), Am Flughafen 12-14, 79108, Freiburg, Germany.
4HF Biotec GmbH, Am Flughafen 14, Freiburg, 79108, Germany.

Swee-Seong Wong (SS)

Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, 46285, USA.
LifeOmic, 351 W 10th St, Indianapolis, IN, USA.

Jason Ting (J)

Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, 46285, USA.

Kerstin Klingner (K)

Charles River Discovery Research Services Germany GmbH (formerly Oncotest GmbH), Am Flughafen 12-14, 79108, Freiburg, Germany.

Bruno Zeitouni (B)

Charles River Discovery Research Services Germany GmbH (formerly Oncotest GmbH), Am Flughafen 12-14, 79108, Freiburg, Germany.

Manuel Landesfeind (M)

Charles River Discovery Research Services Germany GmbH (formerly Oncotest GmbH), Am Flughafen 12-14, 79108, Freiburg, Germany.
Evotec International GmbH, Marie-Curie-Strasse, 37079, Göttingen, Germany.

Woo Ho Kim (WH)

Department of Pathology, Seoul National University College of Medicine, 101 Daehak-ro, Jongnogu, Seoul, Korea.

Hyuk-Joon Lee (HJ)

Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Korea.

Seong-Ho Kong (SH)

Department of Surgery, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, Korea.

Isabella Wulur (I)

Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, 46285, USA.

Steven Bray (S)

Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, 46285, USA.
LifeOmic, 351 W 10th St, Indianapolis, IN, USA.

Peter Bronsert (P)

Institute for Surgical Pathology, Medical Center-University of Freiburg, Freiburg, Germany.
Comprehensive Cancer Center Freiburg, Medical Center-University of Freiburg, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Nina Zanella (N)

Charles River Discovery Research Services Germany GmbH (formerly Oncotest GmbH), Am Flughafen 12-14, 79108, Freiburg, Germany.

Greg Donoho (G)

Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, 46285, USA.

Han-Kwang Yang (HK)

Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, Korea.

Heinz-Herbert Fiebig (HH)

Charles River Discovery Research Services Germany GmbH (formerly Oncotest GmbH), Am Flughafen 12-14, 79108, Freiburg, Germany. fiebig@4hf.eu.
4HF Biotec GmbH, Am Flughafen 14, Freiburg, 79108, Germany. fiebig@4hf.eu.

Christoph Reinhard (C)

Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, 46285, USA. reinhard_christoph@lilly.com.

Amit Aggarwal (A)

Lilly Research Labs, Eli Lilly and Company, Indianapolis, IN, 46285, USA. aggarwal_amit@lilly.com.

Classifications MeSH